|
|
| |
BIT's conferences - 2008 |
|
|
|
|
|
WCC-2008
(June 12-17, 2008, Shanghai, China) |
|
WSA-2008
(July 20-26, 2008, Kunming, China) |
|
|
|
|
|
CEMD-2008
(Oct.22-28, 2008, Beijing & Xi'an, China) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On December 1-5, 2008, BIT 1st World Congress of Vaccine-2008 Focused Event for Vaccine Technology was held successfully in Foshan, China. During the Opening Ceremony, Mr Liu Hailin, Deputy Director-General of China Medicinal Biotech Association; Ms. Zhang weihong, Deputy Mayor, Sanshui District; Ms. Mai Jiehua, Vice Mayor of Foshan City; Dr. Xiaodan Mei, the Executive Chairman of this event; Dr. John B Robbins, Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA , deliver opening remarks and speech to all our participants.
As the keynote speakers, Dr. John B Robbins, Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA; Dr. Michael Favorov, Director General, International Vaccine Institute (IVI), Korea; Dr. Katherine Cohen, VP, Corporate & Business Development, Intercell AG, Austria;made excellent presentations and warmly discussed with the audiences at keynote forum.
|
|
|
|
|
|
To Schedule more than 300 Scientific/Tech and Business/Economics/Policy Presentations on frontier of vaccinology and vaccine development from world class scientists, executives and decision makers |
|
To Call for 50 poster demonstration and 50 expositions of new products and technologies to expand visibilities to the up to 500-800 targeted audiences |
|
To Arrange round table network for business and market development |
|
To Foster friendship through a Warm Tour in the holly season to the ever-spring regions in southern China |
|
|
|
The BIT's 1st Annual World Congress of Vaccine provides highquality and current reports of scientific progress featured in calling for presentations and submitted abstracts presenting at Six Remarkable Tracks, which cover a broad spectrum of current status of Vaccine development in not only human vaccination fields, but also to extend to Livestock, Agricultural and Aquaculture Vaccine R & D and business development. The disparate fields covered in both human and veterinary vaccinology encourage valuable cross-fertilization of ideas and approaches among researchers otherwise focused on specific diseases or methods.
The Congress will be the largest meeting devoted exclusively to the research on vaccines and associated technologies for disease prevention and treatment. Both of international and domestic experts will lead sessions and panel discussions on topical areas of basic science, product development, clinical testing, regulation, and other aspects of vaccine research. Opportunities for networking and scientific collaboration critical to advancing vaccine science and development will be available through audience discussions, poster presentations, sponsored exhibits, and evening ceremonies and receptions.
|
|
|
|
The Eight Remarkable Program Tracks cover a broad spectrum of current status of Vaccine development in not only human vaccination fields, but also to extend to Livestock, Agricultural and aquaculture Vaccine R & D and business development.
|
|
|
|

Presentations-Find the answers you need |

Exhibition-Showcase and Exposure to professionals |
|

Sessions-Get first-hand information |

Partnering-Generate new collaboration |
|
|
|
|
| The key at the conclusion of this conference, participants should be able to meet the following conference objectives: |
|
|
To provide a progressive state-of-the-art report so that researchers and other workers in the field can advance and progress the field knowing what is already available |
| |
To accelerate progress in the development of vaccines to infectious and non-infectious diseases that threaten the well-being of citizens |
| |
To encourage a prophylactic approach to healthcare and discover its boundaries |
| |
To discuss recent scientific advances that are contributing to progress in the development of vaccines |
| |
To identify research opportunities and scientific challenges associated with vaccine development, production and distribution |
The Congress will serve as an interface to bring together researchers, clinicians, epidemiologists, Microbiologists, Immunologists, Molecular Biologists, public health officials, representatives from the pharmaceutical / biotechnology industry, and policy makers from around the world. |
|
|
|
|
|
 |
Dr. John B Robbins
Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA |
|
 |
Dr. John D. Clemens Director General, International Vaccine Institute (IVI), Korea |
|
|
Dr. Alan Shaw
Chief Executive Officer, Vaxinnate Corporation, USA |
|
|
Dr. Peter Khoury
Vice President, Global Marketing Baxter Bioscience-Vaccines, USA |
|
|
Dr. Francis E. Andr¨¦
Ex-Vice President, GlaxoSmithKline Biologicals, Belgium |
|
|
Dr. Jaap Goudsmit
Chief Scientific Officer, Crucell, Netherlands |
|
|
Dr. Katherine Cohen
Vice President, Corporate & Business Development, Intercell AG, Austria |
|
|
Dr.Alexander K. Andrianov
Vice President,
Apogee Technology, Inc. USA
|
|
|
 |
Dr. Kelly Lyn Warfield
Vice President of Vaccine Development
Integrated BioTherapeutics Inc. |
|
 |
Dr. JAMES J. JAMES
Director, AMA Center for Public Health Preparedness and Disaster Response, USA |
|
 |
Dr. Xiaofeng Liang
Director, Chinese CDC & Prevention, National Immunisation Programme, China |
|
|
Dr. Luc Aujame
Director, External R&D, Sanofi Pasteur, France |
|
|
Dr. Jonathan Liu
Director, Research and Development MedImmune, LLC., AstraZeneca, USA |
|
|
Dr. Ralf Kircheis
CSO/Founder, Vela pharm. Entwicklung u. Laboranalytik GmbH, Austria |
|
|
|
|
BIT's 1st Annual World Congress of Vaccine looks forward to welcoming you to Foshan for a stimulating scientific program and secure your position in the industry and reach highly qualified prospects for your products and solutions.
Be an WCV 2008 Sponsor Now!
|
|
|
|
International Vaccine Institute
International AIDS Vaccine Institute
Global TB Vaccine Foundation
Center for Disease Control and Prevention, China
Center for Disease Control and Prevention, USA
Sabin Vaccine Institute, USA
National Institutes of Health , USA
National Human Genome Research, USA
Novartis AG, Switzerland
Merck, USA
Sanofi Pasteur, France
MedImmune, USA
Wyeth, USA
GlaxoSmithKline Biologicals, Belgium
Pfizer, USA
ASTRAZENECA, USA
IOMAI, USA
Baxter, USA
Novozymes A/S, Denmark
Intercell, Austria
Crucell, Netherlands
Apogee Technology, Inc, USA
Acambis, UK
Chiron, USA
VaxGen, USA
Vaxinnate, USA
VaxGen, USA
ViRexx, Canada
Apthera, USA
Maxygen, USA
Virionics, USA
CSC, USA
3M, USA
OptiNose AS, Norway
Civimetrix, Canada
Apotex, Canada
AccuDx, USA
Sigma-Aldrich, USA
Vaxine, Australia
OsteoMed II, USA
CNAPS Medical Devices, Canada
Iman I Mass Awareness Network, Canada
Apotex, Canada
Toxi-Health, USA
Apthera, USA
Bioniche Animal Health, Canada
Ceva-Phylaxia Zrt, Hungary
Biovet Pvt Ltd, India
Egafish Systems, Israel
Integrated BioTherapeutics,USA
Aquatic Diagnostics, UK
Synergy America, USA
Virionics Corporation, USA
immatics biotechnologies GmbH,Germany
Green Hills Biotechnology GmbH, Austria
Gan Shmuel, Israel.
SIOGEN Biotech, Malaysia
University of Cambridge, UK
Medical University of Vienna, Austria
University of Mississippi Medical Center, USA
Utah State University, USA
University of Louvain, Belgium
University of Florida, USA
Oxford University, UK
University of Uberlandia, Brazil
Johns Hopkins University School of Medicine, USA
University of Strasbourg, French
Emory University, USA
University of Glasgow, UK
University of Leicester, UK
Stanford University, USA
University of Minnesota, USA
University of Pennsylvania, USA
University of Pittsburgh, USA
University of Linkoping, Sweden
University of New South Wales, Australia
Colorado State University, USA
University of Tampere, Finland
University of Vienna Waehringer, Austria
University of Quindio, Colombia
Arizona State University, USA
University of California, USA
Seoul National University, Korea
University of Queensland, Australia
University of Washington, USA
University of Ottawa, Canada |
|
|
|
China Medicinal Biotech Association
People's Government of Foshan, China |
|
|
People' s Government of Sanshui District, China
Science & Technology Bureau of Foshan City, China
Dalian BIT Life Sciences, Inc., China |
|
|
Science & Technology Bureau of Foshan Sanshui District, China
The Administrative Committee of Sanshui Industrial Park, Foshan, Guangdong
Publicity Department of CPC of Foshan Sanshui District, China
Kaichuang Investment Co., Ltd., China
Guangzhou Gendustry Inc.
Foshan Sanshui New Energy Medical Devices Investment Co., Ltd
Gendustry Institute of South Medical University
South China Biochip Research Center |
|
|
| |
|
|
|